TAMARAH MASON: Open Payments
NPI 1104867837 · SELMA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 24 payments from 8 companies in 2025. Trend: 2023 $800 · 2024 $626 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| Abbott Laboratories | 3 | $56 |
| RADIOMETER AMERICA, INC | 1 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Exact Sciences Corporation | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: AIRSUPRA, Ozempic, FREESTYLE LIBRE 3, Rybelsus, HemoCue Glucose 201 DM Analyzer, FARXIGA, XIFAXAN, Wegovy.
Industry payments across AL — which companies pay providers there.
